
Sandra E. Saucier
Examiner (ID: 2111)
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1657, 1651, 1808 |
| Total Applications | 1461 |
| Issued Applications | 816 |
| Pending Applications | 208 |
| Abandoned Applications | 438 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7407313
[patent_doc_number] => 20040106094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Red blood cell composition'
[patent_app_type] => new
[patent_app_number] => 10/608200
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3299
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10608200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/608200 | Red blood cell composition | Jun 26, 2003 | Abandoned |
Array
(
[id] => 7333592
[patent_doc_number] => 20040131703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation'
[patent_app_type] => new
[patent_app_number] => 10/600182
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20617
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600182 | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation | Jun 19, 2003 | Abandoned |
Array
(
[id] => 7169369
[patent_doc_number] => 20050202394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Organ arrest, protection, preservation and recovery'
[patent_app_type] => utility
[patent_app_number] => 10/518733
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7827
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518733
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518733 | Organ arrest, protection, preservation and recovery | Jun 19, 2003 | Abandoned |
Array
(
[id] => 5720692
[patent_doc_number] => 20060073467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Biocompatible polymer and filter for selectively eliminating leucocytes using the same'
[patent_app_type] => utility
[patent_app_number] => 10/518351
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15446
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518351 | Biocompatible polymer and filter for selectively eliminating leucocytes using the same | Jun 16, 2003 | Issued |
Array
(
[id] => 7675238
[patent_doc_number] => 20040126880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Sterilization, stabilization and preservation of functional biologics'
[patent_app_type] => new
[patent_app_number] => 10/456983
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8735
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456983
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456983 | Sterilization, stabilization and preservation of functional biologics | Jun 5, 2003 | Abandoned |
| 10/276750 | Dehydroascorbic acid formulations and uses thereof | Jun 5, 2003 | Abandoned |
Array
(
[id] => 6635109
[patent_doc_number] => 20030211592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods of terminal sterilization of biological products'
[patent_app_type] => new
[patent_app_number] => 10/455284
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6951
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211592.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455284 | Methods of terminal sterilization of biological products | Jun 3, 2003 | Abandoned |
Array
(
[id] => 7392501
[patent_doc_number] => 20040038192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'System for exsanguinous metabolic support of an organ or tissue'
[patent_app_type] => new
[patent_app_number] => 10/443452
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20468
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10443452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/443452 | System for exsanguinous metabolic support of an organ or tissue | May 21, 2003 | Abandoned |
Array
(
[id] => 6821550
[patent_doc_number] => 20030219711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Process for treatment of biological tissues'
[patent_app_type] => new
[patent_app_number] => 10/441752
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1510
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441752 | Process for treatment of biological tissues | May 19, 2003 | Abandoned |
Array
(
[id] => 7250630
[patent_doc_number] => 20050142208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Pharmceutical composition for treatment of wounds conntaining blood plasma or serum'
[patent_app_type] => utility
[patent_app_number] => 10/508841
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7127
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508841 | Pharmceutical composition for treatment of wounds conntaining blood plasma or serum | May 8, 2003 | Abandoned |
Array
(
[id] => 7088517
[patent_doc_number] => 20050008629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Encapsulated AGF cells'
[patent_app_type] => utility
[patent_app_number] => 10/434442
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4737
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434442
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434442 | Encapsulated AGF cells | May 6, 2003 | Abandoned |
Array
(
[id] => 435650
[patent_doc_number] => 07261904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Purified cochineal and method for its production'
[patent_app_type] => utility
[patent_app_number] => 10/428995
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5624
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/261/07261904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428995
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428995 | Purified cochineal and method for its production | May 4, 2003 | Issued |
Array
(
[id] => 623442
[patent_doc_number] => 07138250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Method of determining thiopurine methyltransferase activity'
[patent_app_type] => utility
[patent_app_number] => 10/428272
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4884
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428272 | Method of determining thiopurine methyltransferase activity | May 1, 2003 | Issued |
Array
(
[id] => 6769845
[patent_doc_number] => 20030215785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets'
[patent_app_type] => new
[patent_app_number] => 10/425282
[patent_app_country] => US
[patent_app_date] => 2003-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6319
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215785.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425282 | Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets | Apr 27, 2003 | Abandoned |
Array
(
[id] => 6661834
[patent_doc_number] => 20030201160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Removal of adenine during a process of pathogen reducing blood and blood components'
[patent_app_type] => new
[patent_app_number] => 10/423200
[patent_app_country] => US
[patent_app_date] => 2003-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5251
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20030201160.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423200 | Removal of adenine during a pathogen reduction process in whole blood or red blood cell by dilution | Apr 23, 2003 | Issued |
Array
(
[id] => 7381478
[patent_doc_number] => 20040029095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Preserved tissue matrix of a hollow organ, particularly of a blood vessel, a method of producing same, and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/414942
[patent_app_country] => US
[patent_app_date] => 2003-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2323
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414942 | Preserved tissue matrix of a hollow organ, particularly of a blood vessel, a method of producing same, and the use thereof | Apr 15, 2003 | Issued |
Array
(
[id] => 698600
[patent_doc_number] => 07067305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Enzymatic process for the resolution for enantiomeric mixtures of β-lactams'
[patent_app_type] => utility
[patent_app_number] => 10/412114
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5096
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067305.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412114 | Enzymatic process for the resolution for enantiomeric mixtures of β-lactams | Apr 10, 2003 | Issued |
Array
(
[id] => 6874100
[patent_doc_number] => 20030194397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Compositions and minimally invasive methods for treating incomplete tissue repair'
[patent_app_type] => new
[patent_app_number] => 10/412821
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7416
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412821 | Compositions and minimally invasive methods for treating incomplete connective tissue repair | Apr 10, 2003 | Issued |
Array
(
[id] => 4473357
[patent_doc_number] => 07867519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio'
[patent_app_type] => utility
[patent_app_number] => 10/511700
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6606
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/867/07867519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511700 | Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio | Apr 6, 2003 | Issued |
Array
(
[id] => 609392
[patent_doc_number] => 07150991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-19
[patent_title] => 'Method to preserve cells'
[patent_app_type] => utility
[patent_app_number] => 10/402925
[patent_app_country] => US
[patent_app_date] => 2003-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5862
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/150/07150991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10402925
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/402925 | Method to preserve cells | Mar 31, 2003 | Issued |